Protalix BioTherapeutics Inc. | Key People and Executives
Moshe Manor
President, Chief Executive Officer & Director
David Granot
Independent Director
Zeev Bronfeld
Independent Director
Moshe Manor
President, Chief Executive Officer & Director
Yaron Naos
Senior Vice President-Operations
Yossi Maimon
CFO, Secretary, Treasurer & Vice President
Yoseph Shaaltiel
Executive Vice President-Research & Development
Raul Chertkoff
Vice President-Medical Affairs
Ronen Rosenberg
Vice President-Commercial & Product Planning
Einat Brill Almon
Senior Vice President-Product Development
Moshe Chechik
Vice President-Engineering
Michal Kahana
Vice President-Quality Affairs
William Taylor
Vice President-Business Development
Dafna Shelly
Vice President-Human Resources
David Granot
Independent Director
Zeev Bronfeld
Independent Director
| Address |
2 Snunit Street
Carmiel HZ 21614
Israel
|
|
Employees
|
- |
| Website |
http://www.protalix.com |
| Updated |
07/08/2019 |
| Protalix Biotherapeutics, Inc. engages in the development and commercialization of recombinant therapeutic proteins based on ProCellEx plant cell based expression system. It offers Taliglucerase alfa injections under the brand name Elelyso, an enzyme replacement therapy for Gaucher disease. The company's drugs also include Oral Glucocerebrosidase for potential treatment of Gaucher disease; therapeutic proteins for Fabry disease, and immune diseases such as rheumatoid, psoriatic and juvenile idiopathic arthritis, ankylosing, spondylitis, and plaque psoriasis; and protein for biodefense and other indications. |
